What's fair? New ICER re­port shows pay­ers gen­er­al­ly en­sur­ing fair ac­cess to drugs

The non­prof­it In­sti­tute for Clin­i­cal and Eco­nom­ic Re­view on Wednes­day re­leased a new re­port high­light­ing the ways in which pay­ers are gen­er­al­ly en­sur­ing fair ac­cess to pre­scrip­tion drugs, even when based on a set of cri­te­ria set by the non­prof­it.

While not­ing the lack of trans­paren­cy hin­dered the re­port’s re­sults, ICER said that the “great ma­jor­i­ty” of pay­er poli­cies in the for­mu­la­ries eval­u­at­ed are struc­tured in a way to sup­port many key el­e­ments of how ICER de­fines “fair ac­cess.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER